Please assess the completion status of the following clinical trial:

Trial Title: The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* 19 years of age and older~* Undergoing anterior cervical discectomy and fusion (ACDF) for radiculopathy or myelopathy~* No known allergies or sensitivities to steroid or non-steroidal medications~Exclusion Criteria:~* Procedure is being done for revision, trauma, infection or tumor~* Patients with known diagnosed metabolic diseases (diabetes, pancreatitis, gout, electrolyte imbalances, hypertension, hematological abnormalities including gastrointestinal bleeding...)~* Patients with known kidney disease or a creatinine level above the upper limit of normal \>1.27

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control (Type: PLACEBO_COMPARATOR): no steroid or non steroidal anti-inflammatory
- Ketorolac (Type: ACTIVE_COMPARATOR): one time dose of 30mg of IV Ketorolac at time of closure
- dexamethasone (Type: ACTIVE_COMPARATOR): one time dose of 10mg of IV dexamethasone at the time of closure

Based on this trial design, predict the completion outcome and termination type (if applicable).